Chonglou Saponin VIICAS# 68124-04-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 68124-04-9 | SDF | Download SDF |
PubChem ID | 176233 | Appearance | White powder |
Formula | C51H82O21 | M.Wt | 1031.2 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Synonyms | Chonglouoside VII; Dioscinin; 17-Hydroxyparis II; Paris saponin VII; Pennogenin 3-O-rhamnosylchacotrioside; Saponin Tg | ||
Solubility | Soluble in methanol; sparingly soluble in water | ||
SMILES | CC1CCC2(C(C3(C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)OC9C(C(C(C(O9)C)O)O)O)O)O)O)OC2C(C(C(C(O2)C)O)O)O)C)C)O)C)OC1 | ||
Standard InChIKey | FBFJAXUYHGSVFN-IYUYFXHASA-N | ||
Standard InChI | InChI=1S/C51H82O21/c1-20-10-15-50(63-19-20)24(5)51(62)31(72-50)17-29-27-9-8-25-16-26(11-13-48(25,6)28(27)12-14-49(29,51)7)67-47-43(71-45-38(59)35(56)33(54)22(3)65-45)40(61)42(30(18-52)68-47)70-46-39(60)36(57)41(23(4)66-46)69-44-37(58)34(55)32(53)21(2)64-44/h8,20-24,26-47,52-62H,9-19H2,1-7H3/t20-,21+,22+,23+,24-,26+,27-,28+,29+,30-,31+,32+,33+,34-,35-,36+,37-,38-,39-,40+,41+,42-,43-,44+,45+,46+,47-,48+,49+,50-,51-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Chonglou saponin VII shows inhibitory effects on cell proliferation. |
Chonglou Saponin VII Dilution Calculator
Chonglou Saponin VII Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.9697 mL | 4.8487 mL | 9.6974 mL | 19.3949 mL | 24.2436 mL |
5 mM | 0.1939 mL | 0.9697 mL | 1.9395 mL | 3.879 mL | 4.8487 mL |
10 mM | 0.097 mL | 0.4849 mL | 0.9697 mL | 1.9395 mL | 2.4244 mL |
50 mM | 0.0194 mL | 0.097 mL | 0.1939 mL | 0.3879 mL | 0.4849 mL |
100 mM | 0.0097 mL | 0.0485 mL | 0.097 mL | 0.1939 mL | 0.2424 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Royleanone
Catalog No.:BCN3917
CAS No.:6812-87-9
- Roburic acid
Catalog No.:BCN5385
CAS No.:6812-81-3
- JNJ-1661010
Catalog No.:BCC2315
CAS No.:681136-29-8
- AICAR phosphate
Catalog No.:BCC4220
CAS No.:681006-28-0
- 13-Dehydroxyindaconintine
Catalog No.:BCN8403
CAS No.:681-18-9
- Bepridil hydrochloride
Catalog No.:BCC7864
CAS No.:68099-86-5
- 4',5,7-Trihydroxy-6-prenylflavone
Catalog No.:BCN4238
CAS No.:68097-13-2
- Boc-Phe(4-Cl)-OH
Catalog No.:BCC3172
CAS No.:68090-88-0
- Norfloxacin hydrochloride
Catalog No.:BCC4230
CAS No.:68077-27-0
- Trifolirhizin
Catalog No.:BCN4237
CAS No.:6807-83-6
- Megastigm-7-ene-3,5,6,9-tetraol
Catalog No.:BCN5169
CAS No.:680617-50-9
- EMPA
Catalog No.:BCC6226
CAS No.:680590-49-2
- Astressin 2B
Catalog No.:BCC5906
CAS No.:681260-70-8
- Diosgenyl-3-di-β-O-glucopyranoside
Catalog No.:BCC8168
CAS No.:68127-19-5
- Humic acid sodium salt
Catalog No.:BCN1284
CAS No.:68131-04-4
- Jujuboside B1
Catalog No.:BCN3881
CAS No.:68144-21-8
- 1-O-Acetyl britannilactone
Catalog No.:BCN2365
CAS No.:681457-46-5
- Nortetraphyllicine
Catalog No.:BCN4240
CAS No.:68160-76-9
- Isoliensinine
Catalog No.:BCN6331
CAS No.:6817-41-0
- BRL 44408 maleate
Catalog No.:BCC6948
CAS No.:681806-46-2
- 6,8-Diprenylnaringenin
Catalog No.:BCN3000
CAS No.:68236-11-3
- 6-Prenylnaringenin
Catalog No.:BCN2999
CAS No.:68236-13-5
- 2-Hydroxy-3-(hydroxymethyl)anthraquinone
Catalog No.:BCN1380
CAS No.:68243-30-1
- (R)-Oxiracetam
Catalog No.:BCC4169
CAS No.:68252-28-8
Quantitative evaluation and discrimination of wild Paris polyphylla var. yunnanensis (Franch.) Hand.-Mazz from three regions of Yunnan Province using UHPLC-UV-MS and UV spectroscopy couple with partial least squares discriminant analysis.[Pubmed:27665609]
J Nat Med. 2017 Jan;71(1):148-157.
Paris polyphylla var. yunnanensis (Franch.) Hand.-Mazz (PPY) is used widely as an anthelmintic, antimicrobial, and anti-tumor agent. Multiplicate analytical methods have been employed to discriminate PPY from different regions, as well as to identify regions most beneficial to the growing of this species. In this study, a convenient and accurate method was established using ultra high performance liquid chromatography (UHPLC) for simultaneous determination of four steroid saponins (Pa, Pb, polyphyllin VI, and Chonglou Saponin VII). Partial least squares discriminant analysis (PLS-DA) according to UHPLC and UV spectroscopy was applied to analyze 30 samples of PPY from three regions of Yunnan Province in China, and identify significant peaks. The results indicated that the correlation coefficients (r (2)) of all calibration curves were above 0.999, and the inter- and intra-day relative standard deviations (RSD) of retention time and peak areas of common peaks were below 1.78 % and 3.40 %, respectively, with recovery rates of 99.6-103.4 % with RSD =2 %. Quantitative analysis implied that the average values of total saponins in PPY from south Yunnan Province (19.9 mg/g) were higher than in the central (8.79 mg/g) district. Thus, further investigation could focus on the southern region to seek high quality PPY. The analysis found that PLS-DA for ultraviolet (UV) spectroscopy, which could separate the samples from three regions, was more appropriate than UHPLC. Retention times during 20-30.75 min of UHPLC, and absorption at 200-300 nm of the UV spectrum were identified as significant peaks for distinguishing PPY from different regions.
[Effects of Paris polyphylla saponin VII plus silica nano composite on ovarian cancer drug resistance in vitro].[Pubmed:26712407]
Zhonghua Yi Xue Za Zhi. 2015 Jun 16;95(23):1859-61.
OBJECTIVE: To explore the drug resistance of Chonglou Saponin VII plus silica nano complex for ovarian cancer. METHODS: The method of thiazolyl blue tetrazolium blue (MTT) was employed for determining the proliferation inhibition rate of Chonglou Saponin VII plus silica nano composite for SKOV3/DDP drug-resistant human ovarian cancer cell. Flow cytometry and Hoechst 33342 staining were used for detecting apoptosis rate and cell cycle phase distribution. And the changes of apoptosis-related protein were examined by immunoblot assay. RESULTS: There were obvious inhibitory effects of Chonglou Saponin VII on cell proliferation. The inhibition rate increased with rising drug concentration with an obvious dose-effect relationship (P < 0.05). At the same time, the cell proliferation inhibition rate significantly improved at 48 h versus 24 h (P < 0.05). Flow cytometry and Hoechst 33342 staining showed that, after a 24 h treatment of SKOV3/DDP cells with 50 and 100 micromol/L Chonglou Saponin VII, early apoptotic cell ratio significantly increased compared with control group. CONCLUSION: The composite of Paris polyphylla saponin VII and silica nano has obvious proliferation inhibitory effects on SKOV3/DDP cells. And there is a significant concentration dependence and it also has some correlation with time. The above composite can increased the proportion of early apoptotic cell ratio.